Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.
Durham’s Tavros Therapeutics sold to subsidiary of German giant Bayer AG Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback